US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.4100
  • +0.0100+0.71%
Close Feb 14 16:00 ET
  • 1.3700
  • -0.0400-2.84%
Post 20:01 ET
6.62MMarket Cap-0.83P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-69.19%-6.3M
-265.81%-753.17K
-424.00%-1.38M
42.38%-1.07M
-121.63%-3.1M
Net income from continuing operations
39.05%-5.25M
78.26%-884.74K
-264.04%-2.09M
56.26%-908.22K
27.99%-1.37M
-25.03%-8.62M
-160.00%-4.07M
60.92%-575.19K
6.44%-2.08M
-15.93%-1.9M
Operating gains losses
-121.44%-586.71K
-142.34%-1.21M
235.54%654.49K
-96.89%11.03K
-843.92%-41.67K
841.80%2.74M
--2.86M
---482.88K
--354.88K
--5.6K
Depreciation and amortization
-11.19%51.07K
186.58%11.51K
-15.21%15.19K
15.87%15.74K
-60.76%8.63K
-30.77%57.51K
-84.71%4.02K
-59.35%17.92K
324.05%13.58K
131.15%21.99K
Deferred tax
497.97%103.88K
464.78%64.12K
-374.71%-31.48K
-1,505.67%-130.26K
5,856.25%201.5K
-41.82%17.37K
-61.98%11.35K
---6.63K
--9.27K
--3.38K
Other non cash items
85.28%5.39K
--1.46K
920.00%2.3K
461.38%1.63K
-99.96%1
-79.86%2.91K
--0
--225
--290
--2.39K
Change In working capital
86.57%-130.11K
-28.77%274.11K
88.51%-50.6K
-109.59%-57.51K
80.43%-296.11K
-178.36%-969.03K
-50.39%384.82K
-178.19%-440.47K
1,266.98%599.6K
-2,875.35%-1.51M
-Change in receivables
142.01%64.95K
1,045.75%10.13K
67.65%-17.26K
-122.67%-21.49K
147.98%93.57K
-875.51%-154.62K
98.30%-1.07K
-136.63%-53.35K
202.58%94.83K
-758.03%-195.03K
-Change in prepaid assets
85.88%-3.69K
-27.86%79.69K
-22.58%87.04K
-75.68%106.08K
59.65%-276.5K
-125.37%-26.13K
8,598.03%110.47K
681.68%112.43K
1,039.25%436.23K
-1,496.15%-685.26K
-Change in payables and accrued expense
67.99%-198.59K
-34.02%183.69K
62.05%-127K
-8.51%-32.92K
58.35%-222.36K
-167.93%-620.42K
-56.29%278.37K
-182.98%-334.64K
-1,194.20%-30.34K
-311.99%-533.82K
-Change in other working capital
104.30%7.22K
120.66%610
----
----
210.42%109.18K
-183.74%-167.86K
---2.95K
----
----
---98.88K
Cash from discontinued investing activities
Operating cash flow
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-69.19%-6.3M
-265.81%-753.17K
-424.00%-1.38M
42.38%-1.07M
-121.63%-3.1M
Investing cash flow
Cash flow from continuing investing activities
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
-371.47%-26.23K
-509.64%-33.91K
7.69K
Net PPE purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
---271.9K
---350.4K
--0
----
----
--0
--0
--0
----
----
Net other investing changes
228.88%33.8K
--0
----
----
----
---26.23K
---33.91K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-807.80%-238.1K
-933.20%-350.4K
339.80%33.8K
----
----
-371.47%-26.23K
-509.64%-33.91K
--7.69K
----
----
Financing cash flow
Cash flow from continuing financing activities
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
-16.25%5.32M
2,179.59%11.66M
10,750.80%2.41M
66.55%-31.69K
367.83%2.94M
6.35M
Net issuance payments of debt
-4.07%-42.59K
---10.03K
-35.52%-13.47K
15.88%-12.79K
60.09%-6.3K
42.26%-40.92K
--0
79.42%-9.94K
---15.2K
---15.78K
Net common stock issuance
-80.28%2.19M
-85.44%264.28K
575.39%103.39K
--0
-71.33%1.82M
1,808.01%11.12M
181,519,200.00%1.82M
53.18%-21.75K
370.25%2.96M
--6.36M
Proceeds from stock option exercised by employees
595.59%4.1M
-88.31%68.95K
--379.62K
--157.92K
--3.5M
--590.08K
--590.08K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-46.38%6.25M
-86.56%323.21K
1,581.84%469.54K
-95.07%145.13K
-16.25%5.32M
2,179.59%11.66M
3,584.23%2.41M
34.38%-31.69K
367.83%2.94M
--6.35M
Net cash flow
Beginning cash position
4,114.84%5.43M
99.61%7.68M
58.34%8.31M
175.60%9.29M
4,114.84%5.43M
-96.18%128.78K
897.17%3.85M
606.07%5.25M
52.89%3.37M
-96.43%128.78K
Current changes in cash
-78.31%1.16M
-168.25%-1.1M
55.46%-623.4K
-151.73%-969.15K
18.79%3.85M
265.82%5.34M
791.43%1.62M
-291.77%-1.4M
252.70%1.87M
331.73%3.24M
Effect of exchange rate changes
69.40%-11.55K
96.04%-1.5K
-338.44%-2.88K
-464.36%-10.9K
188.14%3.72K
-66.58%-37.73K
-63.90%-37.71K
750.00%1.21K
464.78%2.99K
-1,234.23%-4.22K
End cash Position
21.12%6.57M
21.12%6.57M
99.61%7.68M
58.34%8.31M
175.60%9.29M
4,114.84%5.43M
4,114.84%5.43M
897.17%3.85M
606.07%5.25M
52.89%3.37M
Free cash flow
22.90%-4.86M
-43.02%-1.08M
18.09%-1.13M
-11.55%-1.19M
52.89%-1.46M
-68.94%-6.3M
-256.19%-753.17K
-424.00%-1.38M
42.38%-1.07M
-121.63%-3.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-69.19%-6.3M-265.81%-753.17K-424.00%-1.38M42.38%-1.07M-121.63%-3.1M
Net income from continuing operations 39.05%-5.25M78.26%-884.74K-264.04%-2.09M56.26%-908.22K27.99%-1.37M-25.03%-8.62M-160.00%-4.07M60.92%-575.19K6.44%-2.08M-15.93%-1.9M
Operating gains losses -121.44%-586.71K-142.34%-1.21M235.54%654.49K-96.89%11.03K-843.92%-41.67K841.80%2.74M--2.86M---482.88K--354.88K--5.6K
Depreciation and amortization -11.19%51.07K186.58%11.51K-15.21%15.19K15.87%15.74K-60.76%8.63K-30.77%57.51K-84.71%4.02K-59.35%17.92K324.05%13.58K131.15%21.99K
Deferred tax 497.97%103.88K464.78%64.12K-374.71%-31.48K-1,505.67%-130.26K5,856.25%201.5K-41.82%17.37K-61.98%11.35K---6.63K--9.27K--3.38K
Other non cash items 85.28%5.39K--1.46K920.00%2.3K461.38%1.63K-99.96%1-79.86%2.91K--0--225--290--2.39K
Change In working capital 86.57%-130.11K-28.77%274.11K88.51%-50.6K-109.59%-57.51K80.43%-296.11K-178.36%-969.03K-50.39%384.82K-178.19%-440.47K1,266.98%599.6K-2,875.35%-1.51M
-Change in receivables 142.01%64.95K1,045.75%10.13K67.65%-17.26K-122.67%-21.49K147.98%93.57K-875.51%-154.62K98.30%-1.07K-136.63%-53.35K202.58%94.83K-758.03%-195.03K
-Change in prepaid assets 85.88%-3.69K-27.86%79.69K-22.58%87.04K-75.68%106.08K59.65%-276.5K-125.37%-26.13K8,598.03%110.47K681.68%112.43K1,039.25%436.23K-1,496.15%-685.26K
-Change in payables and accrued expense 67.99%-198.59K-34.02%183.69K62.05%-127K-8.51%-32.92K58.35%-222.36K-167.93%-620.42K-56.29%278.37K-182.98%-334.64K-1,194.20%-30.34K-311.99%-533.82K
-Change in other working capital 104.30%7.22K120.66%610--------210.42%109.18K-183.74%-167.86K---2.95K-----------98.88K
Cash from discontinued investing activities
Operating cash flow 22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-69.19%-6.3M-265.81%-753.17K-424.00%-1.38M42.38%-1.07M-121.63%-3.1M
Investing cash flow
Cash flow from continuing investing activities -807.80%-238.1K-933.20%-350.4K339.80%33.8K-371.47%-26.23K-509.64%-33.91K7.69K
Net PPE purchase and sale --0------------------0----------------
Net investment purchase and sale ---271.9K---350.4K--0----------0--0--0--------
Net other investing changes 228.88%33.8K--0---------------26.23K---33.91K------------
Cash from discontinued investing activities
Investing cash flow -807.80%-238.1K-933.20%-350.4K339.80%33.8K---------371.47%-26.23K-509.64%-33.91K--7.69K--------
Financing cash flow
Cash flow from continuing financing activities -46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K-16.25%5.32M2,179.59%11.66M10,750.80%2.41M66.55%-31.69K367.83%2.94M6.35M
Net issuance payments of debt -4.07%-42.59K---10.03K-35.52%-13.47K15.88%-12.79K60.09%-6.3K42.26%-40.92K--079.42%-9.94K---15.2K---15.78K
Net common stock issuance -80.28%2.19M-85.44%264.28K575.39%103.39K--0-71.33%1.82M1,808.01%11.12M181,519,200.00%1.82M53.18%-21.75K370.25%2.96M--6.36M
Proceeds from stock option exercised by employees 595.59%4.1M-88.31%68.95K--379.62K--157.92K--3.5M--590.08K--590.08K--0--0--0
Cash from discontinued financing activities
Financing cash flow -46.38%6.25M-86.56%323.21K1,581.84%469.54K-95.07%145.13K-16.25%5.32M2,179.59%11.66M3,584.23%2.41M34.38%-31.69K367.83%2.94M--6.35M
Net cash flow
Beginning cash position 4,114.84%5.43M99.61%7.68M58.34%8.31M175.60%9.29M4,114.84%5.43M-96.18%128.78K897.17%3.85M606.07%5.25M52.89%3.37M-96.43%128.78K
Current changes in cash -78.31%1.16M-168.25%-1.1M55.46%-623.4K-151.73%-969.15K18.79%3.85M265.82%5.34M791.43%1.62M-291.77%-1.4M252.70%1.87M331.73%3.24M
Effect of exchange rate changes 69.40%-11.55K96.04%-1.5K-338.44%-2.88K-464.36%-10.9K188.14%3.72K-66.58%-37.73K-63.90%-37.71K750.00%1.21K464.78%2.99K-1,234.23%-4.22K
End cash Position 21.12%6.57M21.12%6.57M99.61%7.68M58.34%8.31M175.60%9.29M4,114.84%5.43M4,114.84%5.43M897.17%3.85M606.07%5.25M52.89%3.37M
Free cash flow 22.90%-4.86M-43.02%-1.08M18.09%-1.13M-11.55%-1.19M52.89%-1.46M-68.94%-6.3M-256.19%-753.17K-424.00%-1.38M42.38%-1.07M-121.63%-3.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025